8-K


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
________________________

FORM 8‑K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported)
   
March 14, 2016

Safeguard Scientifics, Inc.
(Exact Name of Registrant as Specified in Charter)

Pennsylvania
1-5620
23-1609753
(State or other jurisdiction of
(Commission file number)
(I.R.S. Employer ID No.)
incorporation or organization)
   
 
   
   
170 North Radnor-Chester Road
   
   
Suite 200
   
   
Radnor, PA
   
19087
(Address of principal executive offices)
   
(Zip Code)

Registrant's telephone number, including area code
   
610-293-0600
Not applicable
(Former name of former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))















ITEM 8.01.    Other Events.

On March 15, 2016, Safeguard Scientifics, Inc. (the “Company”) issued a press release announcing that the Company’s partner company, Putney, Inc., signed a definitive agreement to be acquired by Dechra Holdings US Inc., a subsidiary of Dechra Pharmaceuticals Plc. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by this reference.

ITEM 9.01.    Financial Statements and Exhibits.

(d)    Exhibits.

99.1    Press Release of Safeguard Scientifics, Inc. dated March 15, 2016.




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
 
Safeguard Scientifics, Inc.
 
 
 
 
Dated:
March 15, 2016
By:
/s/ BRIAN J. SISKO
 
 
 
Brian J. Sisko
 
 
 
Chief Operating Officer, Executive Vice President and Managing Director














































EXHIBIT INDEX
99.1    Press Release of Safeguard Scientifics, Inc. dated March 15, 2016